CHP Staining: Unlocking a New Therapeutic Strategy for Fibrosis
Fibrosis, the pathological accumulation of collagen and other ECM components, is a major health concern implicated in an estimated ⅓ of all natural deaths. While current anti-fibrotic drugs aim to slow progression, advanced fibrosis is often left untreated, leaving transplantation the only remaining option in many cases. A new therapeutic approach is focusing on...
View Details
How Collagen Hybridizing Peptides Reveal Hidden Molecular Damage Behind Back Pain
Hundreds of millions of people suffer from chronic back pain, often stemming from Degenerative Disc Disease (DDD). MRI imaging can visualize the structural decay of spinal discs, but what if DDD pathogenesis starts long before gross morphological degeneration is identified? For years, researchers have hypothesized that the real issues begin on the molecular level...
View Details



